In the recent years, several studies have been focused in understanding the effects of KRAS mutation and TP53 loss in numerous cell models and systems, largely demonstrating that they play a role in cancer cell energy metabolism through regulation of processes, such as glucose transport, lactate metabolism and mitochondrial function. The gene discussed is KRAS; the disease is cancer.